In a recent study, Sayles et al used palbociclib treatment on patient‐derived osteosarcoma xenografts with CDK4 amplifications to show that CDK4/6 inhibition interferes with cell cycle progression, induces cell senescence with apoptosis, and decreases the pRb levels [21]. This evidence concerns the gene RB1 and osteosarcoma.